Can Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) reduce the risk of recurrence after colon resection for colon cancer? : Adjuvant Pressurized IntraPeritonealAerosol Chemotherapy (PIPAC) in resectedhigh risk colon cancer patients.- The PIPAC-OPC3 CC trial - - The PIPAC-OPC3 Trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Recurrence after resection for colon cancer MedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps);Therapeutic area: Diseases [C] - Cancer [C04]
Phase: Phase 2
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 24-06-2017, Last updated: 2023-06-29

ICTRP ID:

EUCTR2017-002637-37-DK
PIPACOPC3CC

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG00471329X